What are the guidelines for using polymyxin, neomycin, and doxycycline ear drops in a patient with a diagnosed bacterial ear infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: January 12, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

Can neomycin‑hydrocortisone ear drops be used in a patient with white otorrhea?

What is the comparative efficacy of neomycin (antibiotic) polymixin B (antibiotic) fluocinolone (corticosteroid) otic drops versus neomycin (antibiotic) polymixin B (antibiotic) dexamethasone (corticosteroid) otic drops for treating otic infections?

Can neomycin (neomycin), polymyxin B (polymyxin B), and fluocinolone (fluocinolone) ear drops cause an allergic reaction on the skin, such as red spots on the chin, when used as directed in the ear?

Can neomycin (antibiotic) polymyxin (antibiotic) ear drops be used in a child with tympanostomy (ear) tubes?

What is the dosing regimen for Cortisporin (neomycin and polymyxin B sulfates and hydrocortisone) drops?

What is the recommended broad-spectrum antibiotic (abx) regimen for intravenous (IV) administration in a patient with suspected severe bacterial infection and impaired renal function, considering potential allergies and recent antibiotic use?

What is the diagnostic evaluation and management approach for apnea in a full-term infant?

What is the immediate management for a patient with suspected increased intracranial pressure in the ICU, possibly following a traumatic brain injury?

How should a patient with unspecified symptoms and medical history be evaluated and treated?

Does Functional Neurological Disorder (FND) affect life expectancy in a young to middle-aged adult patient with no severe comorbidities?

Is there a benefit to extending the 4-drug regimen (isoniazid, rifampin, pyrazinamide, and ethambutol) beyond 2 months for a patient with extensive destructive tuberculosis osteomyelitis due to delayed diagnosis, with a drug-susceptible strain?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.